Liraglutide, a Once-Daily Human GLP-1 Analog, Is Equally Effective and Tolerated Independent of Administration Time (Morning vs Evening)

被引：0
|
作者：
Kaku, Kohei
Rasmussen, Mads
Katayama, Yasuyuki
Seino, Yutaka
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A144 / A144
页数：1
相关论文
共 50 条
  • [1] Mechanism of Protraction for Liraglutide, the Once-Daily Human GLP-1 Analog
    Knudsen, Lotte B.
    Nielsen, Per F.
    Steensgaard, Dorte B.
    Bloch, Paw
    Lau, Jesper
    Agersoe, Henrik
    DIABETES, 2009, 58 : A532 - A532
  • [2] Indacaterol once-daily is equally effective dosed in the evening or morning in COPD
    Magnussen, H.
    Verkindre, C.
    Jack, D.
    Jadayel, D.
    Henley, M.
    Woessner, R.
    Higgins, M.
    Kramer, B.
    RESPIRATORY MEDICINE, 2010, 104 (12) : 1869 - 1876
  • [3] New Aspects to the Once-Daily GLP-1 Mimetic Liraglutide
    Schneider, S.
    DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (05): : 395 - 402
  • [4] The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol
    Kapitza, Christoph
    Flint, Anne
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [5] The molecular basis for the delayed absorption of the once-daily human GLP-1 analoge, liraglutide
    Steensgaard, Dorte B.
    Thomsen, Jens K.
    Olsen, Helle B.
    Knudsen, Lotte B.
    DIABETES, 2008, 57 : A164 - A164
  • [6] Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    Russell-Jones, David
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 137 - 140
  • [7] Liraglutide: A Review of the First Once-Daily GLP-1 Receptor Agonist
    Bode, Bruce
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (02): : S59 - S70
  • [8] Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
    Astrup, A.
    Carraro, R.
    Finer, N.
    Harper, A.
    Kunesova, M.
    Lean, M. E. J.
    Niskanen, L.
    Rasmussen, M. F.
    Rissanen, A.
    Rossner, S.
    Savolainen, M. J.
    Van Gaal, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (06) : 843 - 854
  • [9] Liraglutide, a once-daily human GLP-1 analog, significantly improves β-cell function in subjects with type 2 diabetes
    Matthews, David
    Marre, Michel
    Le-Thl, T. U. Duyen
    Zdravkovic, Milan
    Simo, Rafael
    DIABETES, 2008, 57 : A150 - A151
  • [10] The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance
    Lykkegaard, Kirsten
    Larsen, Philip J.
    Vrang, Niels
    Bock, Camilla
    Bock, Troels
    Knudsen, Lotte Bjerre
    SCHIZOPHRENIA RESEARCH, 2008, 103 (1-3) : 94 - 103
12345